Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - A pilot study

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Hildebrandt, Bert ^a   Müller, Christian ^a   Pezzutto, Antonio ^a   Daniel, Peter T ^a   Dörken, Bernd ^a   Scholz, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LYMPHOMATOSIS; LYMPHOMATOUS MENINGITIS; MALE; MENINGITIS; NEPHELOMETRY; PILOT STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; BLOOD; BRAIN TUMOR; CEREBROSPINAL FLUID; LYMPHOMA; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; LYMPHOMA; MALE; MENINGITIS; MIDDLE AGED; PILOT PROJECTS;

EID: 38149054926     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-185     Document Type: Article

References (20)

1. Liang R Chiu E Loke SL Secondary central nervous system involvement by non-Hodgkin's lymphoma: The risk factors Hematol Oncol 1990, 8(3):141-145. 10.1002/hon.2900080305 2373491
2. Levitt LJ Dawson DM Rosenthal DS Moloney WC CNS involvement in the non-Hodgkin's lymphomas Cancer 1980, 45(3):545-552. 10.1002/ 1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6 6986199
3. Fischer L Jahnke K Martus P Weller M Thiel E Korfel A The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas Haematologica 2006, 91(3):429-430. 16531273
4. Chamberlain MC Nolan C Abrey LE Leukemic and lymphomatous meningitis: incidence, prognosis and treatment J Neurooncol 2005, 75(1):71-83. 10.1007/s11060-004-8100-y 16215818
5. Zeiser R Burger JA Bley TA Windfuhr-Blum M Schulte-Monting J Behringer DM Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - a single centre experience Br J Haematol 2004, 124(6):762-768. 10.1111/j.1365-2141.2004.04853.x 15009064
6. Katzmann JA Clark RJ Abraham RS Bryant S Lymp JF Bradwell AR Kyle RA Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains Clin Chem 2002, 48(9):1437-1444. 12194920
7. Bradwell AR Carr-Smith HD Mead GP Tang LX Showell PJ Drayson MT Drew R Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine Clin Chem 2001, 47(4):673-680. 11274017
8. Bradwell AR Carr-Smith HD Mead GP Harvey TC Drayson MT Serum test for assessment of patients with Bence Jones myeloma Lancet 2003, 361(9356):489-491. 10.1016/S0140-6736(03)12457-9 12583950
9. Drayson M Tang LX Drew R Mead GP Carr-Smith H Bradwell AR Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma Blood 2001, 97(9):2900-2902. 10.1182/ blood.V97.9.2900 11313287
10. Hassoun H Reich L Klimek VM Dhodapkar M Cohen A Kewalramani T Zimman R Drake L Riedel ER Hedvat CV Teruya-Feldstein J Filippa DA Fleisher M Nimer SD Comenzo RL Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma Br J Haematol 2006, 132(2):155-161. 10.1111/ j.1365-2141.2005.05848.x 16398649
11. Pratt G Mead GP Godfrey KR Hu Y Evans ND Chappell MJ Lovell R Bradwell AR The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains Leuk Lymphoma 2006, 47(1):21-28. 10.1080/10428190500254216 16321823
12. Abraham RS Katzmann JA Clark RJ Bradwell AR Kyle RA Gertz MA Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis Am J Clin Pathol 2003, 119(2):274-278. 10.1309/LYWM-47K2-L8XY-FFB3 12579999
13. Rajkumar SV Kyle RA Therneau TM Melton LJ 3rd Bradwell AR Clark RJ Larson DR Plevak MF Dispenzieri A Katzmann JA Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance Blood 2005, 106(3):812-817. 1895159 15855274 10.1182/blood-2005-03-1038
14. Rotbart HA Viral meningitis Semin Neurol 2000, 20(3):277-292. 10.1055/ s-2000-9427 11051293
15. Roos KL Acute bacterial meningitis Semin Neurol 2000, 20(3):293-306. 10.1055/s-2000-9393 11051294
16. Fischer C Arneth B Koehler J Lotz J Lackner KJ Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis Clin Chem 2004, 50(10):1809-1813. 10.1373/clinchem.2004.033977 15271859
17. Borowitz M Bigner SH Johnston WW Diagnostic problems in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia Acta Cytol 1981, 25(6):665-674. 6947670
18. Glantz MJ Cole BF Glantz LK Cobb J Mills P Lekos A Walters BC Recht LD Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results Cancer 1998 82(4):733-739. 10.1002/ (SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z 9477107
19. Thomas JE Falls E Velasco ME Zaher A Diagnostic value of immunocytochemistry in leptomeningeal tumor dissemination Arch Pathol Lab Med 2000, 124(5):759-761. 10782164
20. Reiber H Felgenhauer K Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system Clin Chim Acta 1987, 163(3):319-328. 10.1016/ 0009-8981(87)90250-6 3581475